社交网络干预2型糖尿病成年人遵守饮食:系统审查和元分析协议
Halimatou Alaofè1, Abidemi Okechukwu2, Sarah Yeo2
1Health Promotion Sciences, The University of Arizona, Tucson, Arizona, USA halaofe@arizona.edu.
BMJ open
|November 9, 2024
概括
本系统审查协议评估了社会网络干预措施,以改善2型糖尿病 (T2D) 的饮食遵守. 它旨在为改善糖尿病管理和血糖控制的未来战略提供信息.
科学领域:
- 内分泌学和新陈代谢学
- 公共卫生和卫生服务研究研究
- 行为医学是一种行为医学.
背景情况:
- 理想的饮食坚持对于管理2型糖尿病 (T2D) 和实现长期血糖控制至关重要.
- 对于针对T2D个体通过社交网络准饮食遵守的干预措施的证据有限.
- 社交网络显著影响健康行为,需要评估它们对T2D饮食遵守的影响.
研究的目的:
- 系统地审查社交网络干预措施对2型糖尿病成年人饮食遵守的有效性.
- 为开发未来干预措施提供见解,以改善糖尿病管理.
- 加强对T2D的长期血糖控制策略.
主要方法:
- 从开始到2023年12月,对随机和非随机受控试验 (持续时间≥3个月) 的系统审查.
- 搜索将包括PubMed,Embase,CINAHL,Cochrane,ProQuest和谷歌学者的搜索.
- 数据提取和由两个独立审稿人进行批判性评估,并进行元分析或叙事综合用于数据分析. 使用GRADE评估的偏见风险和证据确定性.
主要成果:
- 本节不适用,因为输出是系统审查的协议.
结论:
- 本系统性审查协议概述了一种全面的方法,用于评估2型糖尿病饮食遵守的社交网络干预措施.
- 研究结果将为开发基于证据的策略提供信息,以改善糖尿病管理和患者的治疗结果.
- 这项研究旨在为利用社交网络提供有价值的见解,以改善T2D成年人的血糖控制.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Insulin: Dosing Regimen and Adverse Effects
146
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
146
Oral Hypoglycemic Agents: Biguanides and Glitazones
174
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
174


